Hofseth Biocare ASA
OSE:HBC
Hofseth Biocare ASA
OSE:HBC
Price:
1.4
NOK
-5.72%
Market Cap:
kr553.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hofseth Biocare ASA
OSE:HBC
|
NO |
|
A
|
Acarix AB
STO:ACARIX
|
SE |
|
Shanxi LuAn Environmental Energy Dev Co Ltd
SSE:601699
|
CN |
|
D&L Industries Inc
OTC:DLNDY
|
PH |
|
Eastside Distilling Inc
NASDAQ:EAST
|
US |
|
T
|
Toshin Group Co Ltd
TSE:2761
|
JP |
|
Haverty Furniture Companies Inc
NYSE:HVT
|
US |
|
V
|
Vibhavadi Medical Center PCL
SET:VIBHA
|
TH |
|
P
|
PPAP Automotive Ltd
NSE:PPAP
|
IN |
|
I
|
IPA Investments Group JSC
VN:IPA
|
VN |
|
GSS Energy Ltd
SGX:41F
|
SG |
|
NSI NV
AEX:NSI
|
NL |
|
Link and Motivation Inc
TSE:2170
|
JP |
|
Samsung Electronics Co Ltd
KRX:005930
|
KR |
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
CN |
|
Blend Labs Inc
NYSE:BLND
|
US |
|
Piedmont Office Realty Trust Inc
NYSE:PDM
|
US |
|
H
|
Hangzhou Robam Appliances Co Ltd
SZSE:002508
|
CN |
|
Javelin Minerals Ltd
ASX:JAV
|
AU |
|
Rukun Raharja Tbk PT
IDX:RAJA
|
ID |
|
CogState Ltd
ASX:CGS
|
AU |
|
A
|
Andean Precious Metals Corp
XTSX:APM
|
CA |
|
D
|
Digicap Co Ltd
KOSDAQ:197140
|
KR |
|
O
|
Oriental Times Media Corp
SZSE:002175
|
CN |
Relative Value
The Relative Value of one
HBC
stock under the Base Case scenario is
hidden
NOK.
Compared to the current market price of 1.4 NOK,
Hofseth Biocare ASA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HBC Relative Value
HIDDEN
Multiples Across Competitors
HBC Competitors Multiples
Hofseth Biocare ASA Competitors
Hofseth Biocare ASA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| NO |
|
Hofseth Biocare ASA
OSE:HBC
|
575.5m NOK | 2.2 | -4.3 | -10.1 | -6.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
